U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07762547) titled 'Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.' on Aug. 09.

Brief Summary: Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease characterized by progressive stenosis or occlusion at the terminal portion of the internal carotid artery, with formation of an abnormal vascular network at the base of the brain. Moyamoya syndrome (MMS) has the same cerebrovascular imaging and clinical manifestations as moyamoya disease, but it is accompanied by other systemic comorbidities. Moyamoya disease and moyamoya syndrome are collectively referred to as moyamoya-like cerebrovascular d...